Incidence of seizures in patients with multiple sclerosis treated with intrathecal baclofen.
about
The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic PotentialSeizures in multiple sclerosis.Walking with modafinil and its use in diplegic cerebral palsy: retrospective review.Temporal lobe cortical pathology and inhibitory GABA interneuron cell loss are associated with seizures in multiple sclerosisConsensus panel guidelines for the use of intrathecal baclofen therapy in poststroke spastic hypertonia.Treatment of seizures in the neurologic intensive care unit.GABA(B) autoreceptor-mediated cell type-specific reduction of inhibition in epileptic mice.Entorhinal Principal Neurons Mediate Brain-stimulation Treatments for Epilepsy.Seizures in patients with multiple sclerosis: epidemiology, pathophysiology and management.The underutilization of intrathecal baclofen in poststroke spasticity.Clinical overview of the seizure risk of dalfampridine.Best Practices for Intrathecal Baclofen Therapy: Patient Selection.Seizure after intrathecal baclofen bolus in a multiple sclerosis patient treated with oxcarbazepine.The failed and future promise of intraspinal drug administration for neurologic disorders.Electroconvulsive therapy in patient with psychotic depression and multiple sclerosis.Clinically isolated syndrome and multiple sclerosis: rethinking the arsenal.Increased cortical inhibition in persons with schizophrenia treated with clozapine.A novel cause of intrathecal baclofen overdosage: lessons to be learnt.Neuromodulation in multiple sclerosis.Phase 2 trial of sustained-release fampridine in chronic spinal cord injury.Pre- and Postsynaptic Activation of GABAB Receptors Modulates Principal Cell Excitation in the Piriform Cortex.
P2860
Q26781422-E02396E3-75E6-450F-A6D6-E76DC7BCFC42Q31149414-57C32F7F-2AE4-4962-8A7E-25ADA974A064Q33253522-4ADD9A7F-802B-4FF9-9BD8-E31092F5213AQ36432965-610D0E4A-B797-4C61-8D38-E19607747E0EQ36643323-63A5EEF6-84F5-4C65-A499-DA69FB1E6C46Q36735141-F07B4BBA-A5DA-4615-A2D6-D30993E92C83Q37173095-AC14FC9C-941A-41F5-BAF2-721D37DF2DE3Q37510252-A88636E7-4A53-4FB8-8E87-CD7786F71EABQ37594075-15B97778-0B8A-4503-AC85-96B74DFF830AQ37885039-B82A0F47-CA3C-47E6-80EA-8802ED68C5E2Q38019055-C213E09C-4A8E-409F-B7C4-D3A14096C238Q38902165-202BA44B-1CBD-431D-BA5D-AEFBCADBF6F3Q42980110-517D2120-68A1-40D5-9550-4EDD8ED77156Q44295791-4406F746-07AC-4EBC-A7EF-9726F5A11938Q44406972-3330B19F-1C96-40CC-A8F7-F18879A5A5DEQ46052203-8016C108-12E1-46D1-894C-BCC606F47542Q46726964-F7D13745-37B0-44B0-A408-00E959871CE7Q46796656-3FA12816-AC43-4011-BAA8-61CCBCB2F74AQ47634105-41F6BF3C-E71D-435F-BAAE-262FAB568651Q48497390-A1893017-631A-40D9-86CE-EF67F87E5C0EQ49829694-7D829972-A4E8-4DA4-807B-9FCEDEAE0FE4
P2860
Incidence of seizures in patients with multiple sclerosis treated with intrathecal baclofen.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Incidence of seizures in patie ...... ted with intrathecal baclofen.
@en
type
label
Incidence of seizures in patie ...... ted with intrathecal baclofen.
@en
prefLabel
Incidence of seizures in patie ...... ted with intrathecal baclofen.
@en
P2093
P1433
P1476
Incidence of seizures in patie ...... ted with intrathecal baclofen.
@en
P2093
Bethoux FA
Kellinghaus C
Loddenkemper T
Schuele SU
P304
P356
10.1212/01.WNL.0000154639.35941.21
P407
P577
2005-03-01T00:00:00Z